Propolis Market Size, Share, Growth, and Industry Analysis, By Type (Capsules & Tablets,Spray,Extract,Others), By Application (Dietary Supplement,Cosmetic Industry,Pharmaceutical Industry), Regional Insights and Forecast to 2035

Propolis Market Overview

The global Propolis Market size is projected to grow from USD 826.31 million in 2026 to USD 873.41 million in 2027, reaching USD 1360.87 million by 2035, expanding at a CAGR of 5.7% during the forecast period.

The Propolis Market has gained significant momentum due to its widespread use in pharmaceuticals, dietary supplements, and cosmetics. Propolis contains more than 300 bioactive compounds, including flavonoids and polyphenols, contributing to its antibacterial, antiviral, and anti-inflammatory properties. In 2023, over 62% of propolis products were sold in dietary supplements, while 24% were applied in cosmetics. Approximately 14% of demand came from pharmaceutical-grade propolis. The global trade volume exceeded 18,000 metric tons annually, with Brazil, China, and New Zealand being the top producers. Rising consumer preference for natural remedies has boosted propolis usage by 31% in the last five years, creating a strong growth trajectory.

The United States is one of the largest consumers of propolis, with demand exceeding 3,200 metric tons annually. Nearly 45% of propolis sold in the U.S. is used in dietary supplements, particularly capsules and tablets. Cosmetics represent 28% of the U.S. market, with skin creams and sprays gaining rapid traction. Around 18% of propolis is used in pharmaceuticals, targeting cold, flu, and oral health products. California, Texas, and New York account for nearly 40% of national demand. Imports primarily come from Brazil and China, covering 60% of supply needs. The rise of organic and clean-label products has further driven adoption by 22% since 2020.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 64% of global consumers prefer natural health products, fueling demand for propolis-based dietary supplements.
• Major Market Restraint: 39% of manufacturers report high variability in raw propolis quality, limiting scalability.
• Emerging Trends: 48% of cosmetic companies are incorporating propolis into skincare formulations.
• Regional Leadership: 41% of global production originates from Asia-Pacific, particularly China.
• Competitive Landscape: 43% of market share is concentrated among top eight companies.
• Market Segmentation: 62% demand arises from dietary supplements, 24% from cosmetics, and 14% from pharmaceuticals.
• Recent Development: 36% rise in spray formulations launched between 2022 and 2024.

Propolis Market Latest Trends

The Propolis Market is experiencing dynamic growth, influenced by health awareness, innovation, and increasing demand across industries. More than 310 new propolis products were launched globally in 2023, with 37% targeting dietary supplements. Capsules and tablets dominated, accounting for 45% of sales, as they offer easy dosage and convenience. Spray products saw a 32% increase in demand, particularly in Europe and North America, driven by oral hygiene and throat care solutions. In cosmetics, propolis-infused creams and serums represented 18% of new launches in 2023. Pharmaceutical applications rose steadily, with over 150 clinical trials examining propolis for antiviral and antibacterial effectiveness. Asia-Pacific accounted for 41% of global production, while Europe held 27% of consumer demand. The global market also saw a 29% increase in e-commerce sales, reflecting the rise of online distribution. This trend highlights consumer trust in natural remedies and multifunctional applications of propolis across diverse industries.

Propolis Market Dynamics

Propolis Market Dynamics describe the forces shaping industry growth, with the market projected from USD 781.75 million in 2025 to USD 1287.48 million by 2034 (CAGR 5.7%). Key drivers include rising demand for natural health supplements, while restraints involve fluctuating raw material availability. Emerging opportunities lie in pharmaceutical and cosmetic applications, with trends pointing to increased adoption of clean-label and functional products.

DRIVER

" Rising Demand for Natural Health Supplements"

The increasing preference for natural remedies is a major driver of the Propolis Market. Surveys show that 64% of consumers worldwide choose natural supplements over synthetic options. Propolis capsules and tablets alone make up 45% of sales globally, reflecting the health-conscious consumer shift. With over 18,000 metric tons of propolis traded annually, rising demand in dietary supplements and pharmaceuticals has boosted product diversification and global investments in propolis-based innovations.

RESTRAINT

" Variability in Raw Propolis Quality"

One of the key restraints in the market is the inconsistent quality of raw propolis. Approximately 39% of manufacturers report difficulties in standardizing active compounds due to variations in botanical and geographic sources. This inconsistency leads to formulation challenges, reduced scalability, and occasional consumer skepticism. For example, propolis sourced from Brazil differs significantly in flavonoid concentration compared to Chinese propolis, creating challenges in global supply chain consistency.

OPPORTUNITY

"Expansion into Skincare and Cosmetics"

Cosmetics present a significant opportunity for the Propolis Market, with 48% of cosmetic companies already incorporating propolis into skincare formulations. Anti-aging and anti-acne properties have fueled demand for propolis-infused serums, creams, and masks. In 2023, the cosmetic industry represented 24% of global propolis consumption, and this is expected to increase as natural and organic product demand rises globally. Innovation in clean-label cosmetics is further expanding propolis applications.

CHALLENGE

"Limited Consumer Awareness in Emerging Regions"

A major challenge for the market is limited awareness in developing economies. Surveys indicate that 55% of consumers in Africa and 47% in South Asia are unaware of propolis and its health benefits. This lack of knowledge slows adoption, despite high availability of raw materials. While countries like Brazil and China dominate production, underdeveloped consumer education campaigns restrict market expansion into emerging regions with untapped potential.

Propolis Market Segmentation

The Propolis Market is segmented by type and application, offering insights into consumer demand patterns across industries. Propolis Market Segmentation divides the global market, valued at USD 781.75 million in 2025 and projected to reach USD 1287.48 million by 2034 (CAGR 5.7%), into types (capsules & tablets: 39.7%, sprays: 18.0%, extracts: 30.0%, others: 12.3%), applications (dietary supplements: 45.0%, cosmetics: 24.0%, pharmaceuticals: 31.0%), and regions (North America: 29.0%, Europe: 27.0%, Asia: 30.0%, Middle East & Africa: 14.0%).

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Capsules & Tablets: Capsules and tablets dominate the market, accounting for 45% of global consumption in 2025, equivalent to over 8,100 metric tons annually. Their convenience and standardized dosage make them the most preferred format. In North America alone, capsules and tablets represent 48% of demand, while in Europe they account for 42%. Growth is driven by the rising adoption of dietary supplements, with 64% of consumers worldwide preferring natural remedies in capsule form.

The capsules & tablets segment is forecasted to achieve USD 310.70 million by 2025 (39.7% share), reaching USD 525.82 million by 2034, expanding at a CAGR of 6.1%, supported by rising demand for convenient supplement formats.

Top 5 Major Dominant Countries in the Capsules & Tablets Segment

• United States: The U.S. capsules & tablets market is estimated at USD 85.6 million in 2025 (27.5% share), reaching USD 148.2 million by 2034, expanding at a CAGR of 6.2% due to strong supplement usage.
• Germany: Germany accounts for USD 41.8 million in 2025 (13.4% share), growing to USD 71.7 million by 2034 with CAGR of 5.9%, driven by demand for herbal supplements.
• China: China’s market is valued at USD 62.1 million in 2025 (20.0% share), projected to hit USD 109.4 million by 2034, with a CAGR of 6.5% fueled by manufacturing strength.
• Japan: Japan contributes USD 40.4 million in 2025 (13.0% share), expected to reach USD 69.6 million by 2034, at a CAGR of 5.8% from nutraceutical demand.
• Brazil: Brazil records USD 36.8 million in 2025 (11.8% share), expanding to USD 64.9 million by 2034, growing at a CAGR of 6.3%, driven by natural wellness trends.

Spray: Sprays hold 22% of the global propolis market, with annual consumption exceeding 3,960 metric tons. Europe leads, consuming 40% of global spray products, while North America accounts for 28%. Demand is particularly strong for throat and oral care sprays, which grew by 32% globally between 2020 and 2023. Germany and France alone represent 35% of European spray demand, reflecting growing consumer preference for convenient, on-the-go formats.

The spray segment will be worth USD 140.7 million in 2025 (18.0% share) and reach USD 227.9 million by 2034, expanding at a CAGR of 5.5%, fueled by its convenience in oral and throat care.

Top 5 Major Dominant Countries in the Spray Segment

• United States: The U.S. spray market stands at USD 39.4 million in 2025 (28.0% share), forecast to hit USD 63.9 million by 2034, at CAGR of 5.6%.
• France: France records USD 20.1 million in 2025 (14.3% share), projected to grow to USD 32.3 million by 2034, expanding at CAGR of 5.4%.
• China: China holds USD 27.6 million in 2025 (19.6% share), expected to reach USD 44.9 million by 2034, growing at CAGR of 5.7%.
• Japan: Japan captures USD 18.4 million in 2025 (13.1% share), projected at USD 30.1 million by 2034, with CAGR of 5.3%.
• Brazil: Brazil reports USD 17.2 million in 2025 (12.2% share), growing to USD 28.7 million by 2034, with CAGR of 5.8%.

Extract: Propolis extracts contribute 21% of global demand, equivalent to more than 4,500 metric tons annually. Extracts are widely used in pharmaceuticals and cosmetics, with Asia-Pacific representing 45% of extract usage. Pharmaceutical companies prefer extracts for ointments, wound healing, and oral care. In cosmetics, extracts accounted for 25% of European propolis consumption in 2023, particularly in skincare serums and creams.

The extract segment is valued at USD 234.5 million in 2025 (30.0% share) and projected to reach USD 395.0 million by 2034, growing at a CAGR of 6.0%, supported by multi-industry applications.

Top 5 Major Dominant Countries in the Extract Segment

• United States: The U.S. extract market stands at USD 66.4 million in 2025 (28.3% share), forecast to hit USD 112.5 million by 2034, growing at CAGR of 6.1%.
• Germany: Germany’s extract market is USD 31.1 million in 2025 (13.3% share), projected at USD 52.5 million by 2034, with CAGR of 5.9%.
• China: China is estimated at USD 46.9 million in 2025 (20.0% share), growing to USD 81.9 million by 2034, expanding at CAGR of 6.3%.
• Japan: Japan records USD 29.6 million in 2025 (12.6% share), expected at USD 50.1 million by 2034, with CAGR of 5.7%.
• Brazil: Brazil contributes USD 27.4 million in 2025 (11.7% share), projected to hit USD 47.9 million by 2034, with CAGR of 6.2%.

Others: Other forms of propolis, including powders, liquids, and specialty blends, account for 12% of global demand, translating to 2,160 metric tons annually. These formats serve niche industries such as veterinary medicine, functional beverages, and nutraceutical innovations. Latin America consumes 18% of this category, while Asia-Pacific represents 35%, with a focus on traditional medicine applications. Demand in the “Others” category has increased by 15% between 2020 and 2023, reflecting experimentation with new product lines.

The "others" category is projected at USD 96.8 million in 2025 (12.3% share) and expected to reach USD 138.7 million by 2034, growing at a CAGR of 5.2% through diversified niche applications.

Top 5 Major Dominant Countries in the Others Segment

• United States: The U.S. market for others stands at USD 27.1 million in 2025 (28.0% share), reaching USD 38.8 million by 2034, at CAGR of 5.3%.
• Italy: Italy records USD 13.8 million in 2025 (14.3% share), projected to grow to USD 19.8 million by 2034, with CAGR of 5.2%.
• China: China achieves USD 18.9 million in 2025 (19.5% share), growing to USD 28.0 million by 2034, expanding at CAGR of 5.4%.
• Japan: Japan is valued at USD 12.6 million in 2025 (13.0% share), forecast to reach USD 18.9 million by 2034, with CAGR of 5.1%.
• Brazil: Brazil’s others segment totals USD 11.7 million in 2025 (12.1% share), expected at USD 17.3 million by 2034, at CAGR of 5.5%.

BY APPLICATION

Dietary Supplement: Dietary supplements dominate the Propolis Market, representing 62% of global demand, equivalent to 11,160 metric tons annually. Capsules and tablets account for the majority, contributing nearly 70% of this segment. North America leads with 45% of dietary supplement consumption, followed by Europe at 30%. In Asia-Pacific, demand grew by 28% between 2020 and 2023, particularly in Japan and South Korea, where consumer preference for natural health products is rising. Global surveys indicate 64% of consumers prefer natural supplements, further boosting demand.

The dietary supplement segment is valued at USD 351.8 million in 2025 (45.0% share) and is projected to reach USD 613.9 million by 2034, expanding at a CAGR of 6.0%, driven by rising health-conscious consumers worldwide.

Top 5 Major Dominant Countries in the Dietary Supplement Application

• United States: Valued at USD 98.2 million in 2025 (27.9% share), projected at USD 171.0 million by 2034, growing at CAGR of 6.1%, supported by robust nutraceutical adoption.
• Germany: Germany records USD 47.1 million in 2025 (13.4% share), expected to reach USD 81.0 million by 2034, with CAGR of 5.9% driven by herbal supplement demand.
• China: China totals USD 70.4 million in 2025 (20.0% share), projected to hit USD 122.2 million by 2034, at CAGR of 6.2% from mass production and strong consumer base.
• Japan: Japan contributes USD 45.7 million in 2025 (13.0% share), estimated to reach USD 79.2 million by 2034, with CAGR of 5.8%.
• Brazil: Brazil reaches USD 42.2 million in 2025 (12.0% share), projected at USD 73.7 million by 2034, growing at CAGR of 6.0%.

Cosmetic Industry: The cosmetic industry contributes 24% of global propolis demand, with annual consumption reaching 4,320 metric tons. Europe is the largest regional consumer, holding 35% of cosmetic-related demand, while Asia-Pacific accounts for 30%. Propolis is widely used in skincare products such as anti-aging serums, creams, and acne care solutions. Between 2020 and 2023, more than 60 new cosmetic products featuring propolis were launched globally. The trend toward natural and clean-label cosmetics has increased demand by 22% since 2020, especially in Germany, France, and South Korea.

The cosmetic industry segment is estimated at USD 187.6 million in 2025 (24.0% share) and expected to reach USD 302.8 million by 2034, expanding at a CAGR of 5.5%, supported by demand for natural beauty ingredients.

Top 5 Major Dominant Countries in the Cosmetic Industry Application

• France: France records USD 34.4 million in 2025 (18.3% share), forecast to reach USD 55.4 million by 2034, growing at CAGR of 5.6%, with strong clean beauty demand.
• Germany: Germany is valued at USD 25.4 million in 2025 (13.5% share), expected to reach USD 41.7 million by 2034, with CAGR of 5.4%.
• China: China’s cosmetic industry holds USD 36.4 million in 2025 (19.4% share), projected to hit USD 60.3 million by 2034, with CAGR of 5.7%.
• Japan: Japan totals USD 24.4 million in 2025 (13.0% share), estimated at USD 39.2 million by 2034, at CAGR of 5.3%.
• United States: U.S. cosmetic application stands at USD 33.8 million in 2025 (18.0% share), expected to reach USD 55.0 million by 2034, growing at CAGR of 5.5%.

Pharmaceutical Industry: Pharmaceutical applications represent 14% of the Propolis Market, equivalent to 2,520 metric tons annually. North America and Europe dominate, accounting for 65% of pharmaceutical demand combined. Propolis is utilized in anti-inflammatory formulations, antiviral solutions, and wound-healing ointments. Over 150 clinical trials have been conducted worldwide to validate its medicinal properties, with a focus on respiratory infections and oral health. Pharmaceutical-grade propolis extracts increased production by 18% between 2020 and 2023, driven by rising demand in the U.S., Germany, and Japan. This segment continues to expand as propolis gains recognition in evidence-based medicine.

The pharmaceutical industry segment is valued at USD 242.3 million in 2025 (31.0% share) and forecasted to hit USD 370.8 million by 2034, growing at a CAGR of 5.8%, supported by proven medicinal benefits of propolis.

Top 5 Major Dominant Countries in the Pharmaceutical Industry Application

• United States: The U.S. pharmaceutical segment stands at USD 67.8 million in 2025 (28.0% share), projected to reach USD 103.6 million by 2034, expanding at CAGR of 5.9%.
• Germany: Germany contributes USD 32.8 million in 2025 (13.5% share), expected at USD 50.2 million by 2034, with CAGR of 5.7%.
• China: China achieves USD 48.4 million in 2025 (20.0% share), reaching USD 74.4 million by 2034, at CAGR of 6.0%.
• Japan: Japan holds USD 31.5 million in 2025 (13.0% share), forecast to hit USD 48.0 million by 2034, with CAGR of 5.6%.
• Brazil: Brazil reports USD 29.0 million in 2025 (12.0% share), expected to grow to USD 44.6 million by 2034, at CAGR of 5.7%.

Regional Outlook for the Propolis Market

The Propolis Market demonstrates strong regional variations, with Asia-Pacific holding 41% of production, Europe 27% of demand, North America 22%, and Middle East & Africa 10%. Regional Outlook for the Propolis Market refers to the analysis of market performance, growth potential, and consumer demand across different geographical regions, highlighting variations in market size, share, and CAGR by North America, Europe, Asia, and Middle East & Africa.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

The region accounts for 22% of global demand, valued at over 3,960 metric tons in 2025. The U.S. dominates with 70% share, followed by Canada at 20% and Mexico at 10%. Spray products represent 32% of U.S. demand, while capsules and tablets account for 45%. Dietary supplements drive 65% of North American demand, while pharmaceuticals contribute 20%.

The North America propolis market is valued at USD 226.7 million in 2025 (29.0% share), projected to reach USD 376.9 million by 2034, growing at a CAGR of 5.8%, driven by high dietary supplement adoption.

North America - Major Dominant Countries in the Propolis Market

• United States: Valued at USD 176.8 million in 2025 (77.9% share), projected at USD 293.2 million by 2034, expanding at CAGR of 5.9%.
• Canada: Canada accounts for USD 27.2 million in 2025 (12.0% share), expected at USD 44.0 million by 2034, with CAGR of 5.7%.
• Mexico: Mexico totals USD 15.9 million in 2025 (7.0% share), forecasted at USD 25.4 million by 2034, growing at CAGR of 5.8%.
• Cuba: Cuba reports USD 4.5 million in 2025 (2.0% share), reaching USD 7.0 million by 2034, with CAGR of 5.6%.
• Dominican Republic: Dominican Republic holds USD 2.3 million in 2025 (1.0% share), expected at USD 3.7 million by 2034, with CAGR of 5.5%.

EUROPE

Europe holds 27% of global demand, consuming over 4,860 metric tons annually. Germany, France, and the UK represent 60% of European demand, with Germany alone consuming 1,200 metric tons. Cosmetics account for 35% of regional demand, particularly in anti-aging formulations. Extracts represent 25% of European consumption, driven by pharmaceutical companies using propolis in ointments and wound-healing creams.

The Europe propolis market is projected at USD 210.6 million in 2025 (27.0% share) and estimated to reach USD 346.6 million by 2034, expanding at CAGR of 5.6%, supported by strong demand for natural cosmetics and supplements.

Europe - Major Dominant Countries in the Propolis Market

• Germany: Germany leads with USD 59.0 million in 2025 (28.0% share), projected at USD 96.9 million by 2034, growing at CAGR of 5.9%.
• France: France totals USD 45.0 million in 2025 (21.4% share), reaching USD 72.6 million by 2034, with CAGR of 5.6%.
• Italy: Italy achieves USD 29.5 million in 2025 (14.0% share), expected at USD 46.7 million by 2034, with CAGR of 5.4%.
• Spain: Spain reports USD 25.3 million in 2025 (12.0% share), forecast at USD 40.0 million by 2034, with CAGR of 5.5%.
• United Kingdom: U.K. contributes USD 21.1 million in 2025 (10.0% share), projected at USD 33.3 million by 2034, with CAGR of 5.4%.

ASIA-PACIFIC

Asia-Pacific accounts for 41% of global production and 26% of demand, producing nearly 7,380 metric tons annually. China dominates with 55% of regional production, while Japan and South Korea consume 40% of demand in dietary and cosmetic applications. Propolis usage in dietary supplements grew by 28% in Japan and 23% in South Korea between 2020 and 2023.

The Asia market is valued at USD 234.5 million in 2025 (30.0% share), projected to hit USD 390.0 million by 2034, growing at CAGR of 6.0%, fueled by manufacturing strength and high propolis consumption.

Asia - Major Dominant Countries in the Propolis Market

• China: China leads at USD 93.8 million in 2025 (40.0% share), expected at USD 156.0 million by 2034, with CAGR of 6.2%.
• Japan: Japan holds USD 46.9 million in 2025 (20.0% share), projected at USD 78.4 million by 2034, at CAGR of 5.7%.
• India: India records USD 35.2 million in 2025 (15.0% share), forecast to hit USD 58.7 million by 2034, with CAGR of 6.1%.
• South Korea: South Korea totals USD 29.3 million in 2025 (12.5% share), reaching USD 48.0 million by 2034, at CAGR of 5.9%.
• Indonesia: Indonesia achieves USD 23.5 million in 2025 (10.0% share), projected at USD 38.4 million by 2034, growing at CAGR of 6.0%.

MIDDLE EAST & AFRICA

This region holds 10% of global demand, consuming over 1,800 metric tons annually. Saudi Arabia accounts for 35% of demand, while South Africa contributes 25%. In the Middle East, 40% of propolis demand comes from pharmaceutical formulations, while in Africa, 50% is from dietary supplements. Awareness remains low, but demand has grown by 19% since 2020.

The Middle East & Africa market is projected at USD 109.4 million in 2025 (14.0% share), forecast to reach USD 174.9 million by 2034, growing at CAGR of 5.4%, driven by increasing awareness of herbal medicine.

Middle East and Africa - Major Dominant Countries in the Propolis Market

• Saudi Arabia: Saudi Arabia leads with USD 27.4 million in 2025 (25.0% share), projected to reach USD 43.8 million by 2034, with CAGR of 5.5%.
• South Africa: South Africa records USD 23.0 million in 2025 (21.0% share), expected at USD 36.4 million by 2034, with CAGR of 5.3%.
• UAE: UAE contributes USD 16.4 million in 2025 (15.0% share), forecast to reach USD 26.2 million by 2034, expanding at CAGR of 5.4%.
• Egypt: Egypt totals USD 12.0 million in 2025 (11.0% share), projected to grow to USD 19.1 million by 2034, with CAGR of 5.3%.
• Nigeria: Nigeria holds USD 10.9 million in 2025 (10.0% share), expected at USD 17.3 million by 2034, at CAGR of 5.4%.

List of Top Propolis Companies

• Comvita
• Changge Huairui Bee Products Co., Ltd
• Jiangshan Hengliang
• Jiangsu Rigao Bee Products
• Hangzhou Reelynn Apiculture Co., Ltd.
• Honey Feast
• Baihua
• MN Propolis

Comvita: Holds 18% of global market share, with sales exceeding 3,200 metric tons annually across 30 countries.

Changge Huairui Bee Products Co., Ltd: Accounts for 15% share, producing over 2,700 metric tons annually with strong exports to North America and Europe.

Investment Analysis and Opportunities

Investments in the Propolis Market are increasing due to strong consumer demand for natural products. More than 120 new manufacturing facilities were established globally between 2020 and 2023. Nearly 45% of investments targeted dietary supplements, while 28% focused on cosmetics. Pharmaceutical companies invested in over 150 clinical studies on propolis efficacy, strengthening product credibility. Venture capital funding in natural health startups rose by 22% annually since 2020, supporting propolis-based product launches. Asia-Pacific received the largest share of investments, with China and India collectively accounting for 40% of global funding. Opportunities lie in expanding into underpenetrated regions like Africa and South Asia, where awareness campaigns could increase adoption by 30% over the next decade.

New Product Development

Innovation is at the core of the Propolis Market, with 310 new products launched globally in 2023 alone. Capsules and tablets dominated launches, representing 45% of new entries, followed by sprays at 32%. Cosmetic brands developed over 60 new propolis-based creams and serums, targeting anti-aging and acne care. Pharmaceutical innovation included 15 new propolis-based ointments for wound healing and oral care. E-commerce platforms saw a 29% increase in online-exclusive product launches, expanding global accessibility. Research institutions partnered with manufacturers to develop standardized propolis extracts with consistent flavonoid concentrations, addressing quality challenges. Sustainability also drove innovation, with 18% of new products adopting eco-friendly packaging and clean-label certifications.

Five Recent Developments

• In 2023, Comvita launched a propolis-infused skincare line, increasing cosmetic sales by 25% globally.
• In 2023, Changge Huairui expanded production by 20%, adding new processing facilities in Asia.
• In 2024, Honey Feast introduced 12 organic propolis spray products, accounting for 15% growth in U.S. sales.
• In 2024, MN Propolis developed a pharmaceutical-grade extract, increasing clinical trial participation by 18%.
• In 2025, Baihua invested in sustainable packaging, cutting plastic use by 30% across its product line.

Report Coverage of Propolis Market

The Propolis Market Report provides comprehensive insights into production, consumption, and trade across more than 50 countries. The report highlights segmentation by type, showing capsules and tablets dominating with 45% share, followed by sprays at 22%, extracts at 21%, and others at 12%. By application, dietary supplements represent 62% of demand, cosmetics 24%, and pharmaceuticals 14%. Regional analysis covers Asia-Pacific’s 41% production share, Europe’s 27% consumption, North America’s 22% demand, and Middle East & Africa’s 10% usage. The report also covers more than 150 clinical trials, 310 new product launches, and 120 new investments since 2020. Competitive analysis examines top companies, with Comvita holding 18% global share and Changge Huairui at 15%. This detailed coverage offers valuable market insights for stakeholders, investors, and manufacturers seeking Propolis Market Growth, Propolis Market Opportunities, and Propolis Market Forecast.

Propolis Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 826.31 Million in 2026
Market Size Value By	USD 1360.87 Million by 2035
Growth Rate	CAGR of 5.7% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Capsules & Tablets Spray Extract Others By Application : Dietary Supplement Cosmetic Industry Pharmaceutical Industry
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample